SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.
化学名称: (1RS)-1-[[(1-Methylethoxy)carbonyl]oxy]ethyl (6R,7R)-7-[[(2Z)-2-[(2-formylamino)thiazol-4-yl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (as per EP)
异名: N-Formyl Cefpodoxime Proxetil
Shipping Temperature: Ambient
HSN Code: 38229010
Country of Origin: India
微笑: O=C(C(N12)=C(COC)CS[C@]2([H])[C@H](NC(/C(C3=CSC(NC=O)=N3)=N\OC)=O)C1=O)OC(OC(OC(C)C)=O)C
Cefpodoxime Proxetil EP Impurity F is chemically (1RS)-1-[[(1-Methylethoxy)carbonyl]oxy]ethyl (6R,7R)-7-[[(2Z)-2-[(2-formylamino)thiazol-4-yl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (as per EP). It is also known as N-Formyl Cefpodoxime Proxetil. Cefpodoxime Proxetil EP Impurity F is supplied with detailed characterization data compliant with regulatory guideline. Cefpodoxime Proxetil EP Impurity F can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cefpodoxime Proxetil.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Stability indicating HPLC method development and validation for the simultaneous determination of Cefpodoxime Proxetil and Ofloxacin in its dosage forms
By Ghode, Prashant D.; Pawar, Sunil P.
From International Journal of Pharma and Bio Sciences (2015), 6(2), 183-193
Stability indicating method development degradation studies and validation of cefpodoxime proxetil by RP-HPLC method
By Kamalesh, G.; Madhuri, D.; Nagarajan, G.
From International Journal for Pharmaceutical Research Scholars (2014), 3(4), 269-275, 7 pp..
Characterization of impurities in cefpodoxime proxetil using LC-MS (n)
By Li Jin; Zhang Dousheng; Hu Changqin
From Acta pharmaceutica Sinica. B (2014), 4(4), 322-32